Use of the FebriDx® host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care: a mixed-methods feasibility study
Oxford Academic Site
- Forums
- ASX - By Stock
- Ann: Lumos Achieves Key Phase 1 Milestone in Hologic Agreement
Use of the FebriDx® host-response point-of-care test may reduce...
Featured News
Add LDX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
-0.002(6.25%) |
Mkt cap ! $23.11M |
Open | High | Low | Value | Volume |
3.0¢ | 3.2¢ | 3.0¢ | $18.53K | 591.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 253332 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 318656 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 253332 | 0.030 |
6 | 315474 | 0.029 |
6 | 630000 | 0.028 |
2 | 274074 | 0.027 |
2 | 378500 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 318656 | 6 |
0.033 | 924565 | 4 |
0.038 | 216001 | 1 |
0.040 | 100000 | 1 |
0.042 | 275655 | 3 |
Last trade - 14.27pm 18/11/2024 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online